REPORT ID 15311

United States Monoclonal Antibody Based Products Market Report 2017

Publish Date
29-Nov-17
Pages
123
Format
Electronic (PDF)

In this report, the United States Monoclonal Antibody Based Products market is valued at USD XX million in 2016 and is expected to reach USD XX million by the end of 2022, growing at a CAGR of XX% between 2016 and 2022.

Geographically, this report splits the United States market into seven regions:
    The West
    Southwest
    The Middle Atlantic
    New England
    The South
    The Midwest
with sales (volume), revenue (value), market share and growth rate of Monoclonal Antibody Based Products in these regions, from 2012 to 2022 (forecast).

United States Monoclonal Antibody Based Products market competition by top manufacturers/players, with Monoclonal Antibody Based Products sales volume, price, revenue (Million USD) and market share for each manufacturer/player; the top players including
    Amgen
    BD Biosciences
    Biogen Idec
    Biotest
    CMC ICOS Biologics
    Dendreon
    Elan Corporations
    Eli Lilly and Company
    Genentech
    Human Genome Sciences
    Immunomedics
    Johnson & Johnson
    Centocor
    Ortho Biotech Products
    Medarex
    MedImmune
    PDL BioPharma
    Schering-Plough
    Strategic Diagnostics
    UCB
    Wyeth Pharmaceuticals

On the basis of product, this report displays the production, revenue, price, market share and growth rate of each type, primarily split into
    Murine
    Chimeric
    Humanized
    Human?
On the basis on the end users/applications, this report focuses on the status and outlook for major applications/end users, sales volume, market share and growth rate of Monoclonal Antibody Based Products for each application, including
    Therapeutics
    Diagnostics

If you have any special requirements, please let us know and we will offer you the report as you want.

 
			   
Table of Contents

United States Monoclonal Antibody Based Products Market Report 2017
1 Monoclonal Antibody Based Products Overview
    1.1 Product Overview and Scope of Monoclonal Antibody Based Products
    1.2 Classification of Monoclonal Antibody Based Products by Product Category
        1.2.1 United States Monoclonal Antibody Based Products Market Size (Sales Volume) Comparison by Type (2012-2022)
        1.2.2 United States Monoclonal Antibody Based Products Market Size (Sales Volume) Market Share by Type (Product Category) in 2016
        1.2.3 Murine
        1.2.4 Chimeric
        1.2.5 Humanized
        1.2.6 Human?
    1.3 United States Monoclonal Antibody Based Products Market by Application/End Users
        1.3.1 United States Monoclonal Antibody Based Products Market Size (Consumption) and Market Share Comparison by Application (2012-2022)
        1.3.2 Therapeutics
        1.3.3 Diagnostics
    1.4 United States Monoclonal Antibody Based Products Market by Region
        1.4.1 United States Monoclonal Antibody Based Products Market Size (Value) Comparison by Region (2012-2022)
        1.4.2 The West Monoclonal Antibody Based Products Status and Prospect (2012-2022)
        1.4.3 Southwest Monoclonal Antibody Based Products Status and Prospect (2012-2022)
        1.4.4 The Middle Atlantic Monoclonal Antibody Based Products Status and Prospect (2012-2022)
        1.4.5 New England Monoclonal Antibody Based Products Status and Prospect (2012-2022)
        1.4.6 The South Monoclonal Antibody Based Products Status and Prospect (2012-2022)
        1.4.7 The Midwest Monoclonal Antibody Based Products Status and Prospect (2012-2022)
    1.5 United States Market Size (Value and Volume) of Monoclonal Antibody Based Products (2012-2022)
        1.5.1 United States Monoclonal Antibody Based Products Sales and Growth Rate (2012-2022)
        1.5.2 United States Monoclonal Antibody Based Products Revenue and Growth Rate (2012-2022)

2 United States Monoclonal Antibody Based Products Market Competition by Players/Suppliers
    2.1 United States Monoclonal Antibody Based Products Sales and Market Share of Key Players/Suppliers (2012-2017)
    2.2 United States Monoclonal Antibody Based Products Revenue and Share by Players/Suppliers (2012-2017)
    2.3 United States Monoclonal Antibody Based Products Average Price by Players/Suppliers (2012-2017)
    2.4 United States Monoclonal Antibody Based Products Market Competitive Situation and Trends
        2.4.1 United States Monoclonal Antibody Based Products Market Concentration Rate
        2.4.2 United States Monoclonal Antibody Based Products Market Share of Top 3 and Top 5 Players/Suppliers
        2.4.3 Mergers & Acquisitions, Expansion in United States Market
    2.5 United States Players/Suppliers Monoclonal Antibody Based Products Manufacturing Base Distribution, Sales Area, Product Type

3 United States Monoclonal Antibody Based Products Sales (Volume) and Revenue (Value) by Region (2012-2017)
    3.1 United States Monoclonal Antibody Based Products Sales and Market Share by Region (2012-2017)
    3.2 United States Monoclonal Antibody Based Products Revenue and Market Share by Region (2012-2017)
    3.3 United States Monoclonal Antibody Based Products Price by Region (2012-2017)

4 United States Monoclonal Antibody Based Products Sales (Volume) and Revenue (Value) by Type (Product Category) (2012-2017)
    4.1 United States Monoclonal Antibody Based Products Sales and Market Share by Type (Product Category) (2012-2017)
    4.2 United States Monoclonal Antibody Based Products Revenue and Market Share by Type (2012-2017)
    4.3 United States Monoclonal Antibody Based Products Price by Type (2012-2017)
    4.4 United States Monoclonal Antibody Based Products Sales Growth Rate by Type (2012-2017)

5 United States Monoclonal Antibody Based Products Sales (Volume) by Application (2012-2017)
    5.1 United States Monoclonal Antibody Based Products Sales and Market Share by Application (2012-2017)
    5.2 United States Monoclonal Antibody Based Products Sales Growth Rate by Application (2012-2017)
    5.3 Market Drivers and Opportunities

6  United States Monoclonal Antibody Based Products Players/Suppliers Profiles and Sales Data
    6.1 Amgen
        6.1.1 Company Basic Information, Manufacturing Base and Competitors
        6.1.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.1.2.1 Product A
            6.1.2.2 Product B
        6.1.3 Amgen Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.1.4 Main Business/Business Overview
    6.2 BD Biosciences
        6.2.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.2.2.1 Product A
            6.2.2.2 Product B
        6.2.3 BD Biosciences Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.2.4 Main Business/Business Overview
    6.3 Biogen Idec
        6.3.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.3.2.1 Product A
            6.3.2.2 Product B
        6.3.3 Biogen Idec Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.3.4 Main Business/Business Overview
    6.4 Biotest
        6.4.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.4.2.1 Product A
            6.4.2.2 Product B
        6.4.3 Biotest Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.4.4 Main Business/Business Overview
    6.5 CMC ICOS Biologics
        6.5.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.5.2.1 Product A
            6.5.2.2 Product B
        6.5.3 CMC ICOS Biologics Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.5.4 Main Business/Business Overview
    6.6 Dendreon
        6.6.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.6.2.1 Product A
            6.6.2.2 Product B
        6.6.3 Dendreon Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.6.4 Main Business/Business Overview
    6.7 Elan Corporations
        6.7.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.7.2.1 Product A
            6.7.2.2 Product B
        6.7.3 Elan Corporations Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.7.4 Main Business/Business Overview
    6.8 Eli Lilly and Company
        6.8.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.8.2.1 Product A
            6.8.2.2 Product B
        6.8.3 Eli Lilly and Company Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.8.4 Main Business/Business Overview
    6.9 Genentech
        6.9.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.9.2.1 Product A
            6.9.2.2 Product B
        6.9.3 Genentech Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.9.4 Main Business/Business Overview
    6.10 Human Genome Sciences
        6.10.2 Monoclonal Antibody Based Products Product Category, Application and Specification
            6.10.2.1 Product A
            6.10.2.2 Product B
        6.10.3 Human Genome Sciences Monoclonal Antibody Based Products Sales, Revenue, Price and Gross Margin (2012-2017)
        6.10.4 Main Business/Business Overview
    6.11 Immunomedics
    6.12 Johnson & Johnson
    6.13 Centocor
    6.14 Ortho Biotech Products
    6.15 Medarex
    6.16 MedImmune
    6.17 PDL BioPharma
    6.18 Schering-Plough
    6.19 Strategic Diagnostics
    6.20 UCB
    6.21 Wyeth Pharmaceuticals

7 Monoclonal Antibody Based Products Manufacturing Cost Analysis
    7.1 Monoclonal Antibody Based Products Key Raw Materials Analysis
        7.1.1 Key Raw Materials
        7.1.2 Price Trend of Key Raw Materials
        7.1.3 Key Suppliers of Raw Materials
        7.1.4 Market Concentration Rate of Raw Materials
    7.2 Proportion of Manufacturing Cost Structure
        7.2.1 Raw Materials
        7.2.2 Labor Cost
        7.2.3 Manufacturing Expenses
    7.3 Manufacturing Process Analysis of Monoclonal Antibody Based Products

8 Industrial Chain, Sourcing Strategy and Downstream Buyers
    8.1 Monoclonal Antibody Based Products Industrial Chain Analysis
    8.2 Upstream Raw Materials Sourcing
    8.3 Raw Materials Sources of Monoclonal Antibody Based Products Major Manufacturers in 2016
    8.4 Downstream Buyers

9 Marketing Strategy Analysis, Distributors/Traders
    9.1 Marketing Channel
        9.1.1 Direct Marketing
        9.1.2 Indirect Marketing
        9.1.3 Marketing Channel Development Trend
    9.2 Market Positioning
        9.2.1 Pricing Strategy
        9.2.2 Brand Strategy
        9.2.3 Target Client
    9.3 Distributors/Traders List

10 Market Effect Factors Analysis
    10.1 Technology Progress/Risk
        10.1.1 Substitutes Threat
        10.1.2 Technology Progress in Related Industry
    10.2 Consumer Needs/Customer Preference Change
    10.3 Economic/Political Environmental Change

11 United States Monoclonal Antibody Based Products Market Size (Value and Volume) Forecast (2017-2022)
    11.1 United States Monoclonal Antibody Based Products Sales Volume, Revenue Forecast (2017-2022)
    11.2 United States Monoclonal Antibody Based Products Sales Volume Forecast by Type (2017-2022)
    11.3 United States Monoclonal Antibody Based Products Sales Volume Forecast by Application (2017-2022)
    11.4 United States Monoclonal Antibody Based Products Sales Volume Forecast by Region (2017-2022)

12 Research Findings and Conclusion

13 Appendix
    13.1 Methodology/Research Approach
        13.1.1 Research Programs/Design
        13.1.2 Market Size Estimation
        13.1.3 Market Breakdown and Data Triangulation
    13.2 Data Source
        13.2.1 Secondary Sources
        13.2.2 Primary Sources
    13.3 Disclaimer